HLA B7 Antibodyfrom GenWay Biotech |
|
GWB-A1EA1E | 0.2 mg: Ask for price | |
HLA-B7 Antibodyfrom Abbexa |
|
abx140248-01mg | 0.1 mg: 444.00 EUR | |
HLA-B7 antibodyfrom Fitzgerald |
|
10-S9201M000-MG | 1 ml: 100.00 EUR | |
Description: Mouse monoclonal HLA-B7 antibody |
|
HLA-B7 antibodyfrom Fitzgerald |
|
10-S9201MND1-M0 | 1 mg: 100.00 EUR | |
Description: Mouse monoclonal HLA-B7 antibody |
|
HLA-B7 Antibodyfrom Abbexa |
|
abx140248-100g | 100 µg: 287.50 EUR | |
Leukocyte Antigen B7 (HLA-B7) Antibodyfrom Abbexa |
|
abx415680-02mg | 0.2 mg: 678.00 EUR | |
HLA B7 Rabbit mAbfrom Abclonal |
|
A8752 | 50μL: 1557.40 EUR | |
Description: A synthetic peptide corresponding to a sequence within amino acids 50-150 of human ApoB (P04114). |
|
HLA B7 Rabbit mAbfrom SAB |
|
56703 | 100ul: 339.00 EUR | |
HLA B7 Antibody (RPE)from GenWay Biotech |
|
GWB-4FAD10 | 100 TESTS: Ask for price | |
HLA-B7 Antibody (PE)from Abbexa |
|
abx140276-100tests | 100 tests: 577.20 EUR | |
HLA B7 Antibody (FITC)from GenWay Biotech |
|
GWB-CF2C6C | 0.1 mg: Ask for price | |
HLA-B7 Antibody (PE)from Abbexa |
|
abx140276-100g | 100 µg: 400.00 EUR | |
Leukocyte Antigen B7 (HLA-B7) Antibody (RPE)from Abbexa |
|
abx415682-100tests | 100 tests: 710.40 EUR | |
Leukocyte Antigen B7 (HLA-B7) Antibody (FITC)from Abbexa |
|
abx415681-01mg | 0.1 mg: 610.80 EUR | |
Major Histocompatibility Complex Class I B7 (HLA-B7) Antibodyfrom Abbexa |
|
abx415680-200l | 200 µl: 462.50 EUR | |
Major Histocompatibility Complex Class I B7 (HLA-B7) Antibody (PE)from Abbexa |
|
abx415682-200l | 200 µl: 487.50 EUR | |
Major Histocompatibility Complex Class I B7 (HLA-B7) Antibody (FITC)from Abbexa |
|
abx415681-200l | 200 µl: 400.00 EUR | |
OASA02888-100T - HLA B7 Antibody - PE Conjugatedfrom Aviva Systems Biology |
|
OASA02888-100T | 100Tests: 479.00 EUR | |
Anti-HLA-B7 Purifiedfrom ExBio |
|
11-547-C025 | 0.025 mg: 77.00 EUR | |
Anti-HLA-B7 Purifiedfrom ExBio |
|
11-547-C100 | 0.1 mg: 154.00 EUR | |
Anti-HLA-B7 PEfrom ExBio |
|
1P-547-T100 | 100 tests: 242.00 EUR | |
Mouse Anti Human Hla B7 Monoclonal Antibody,RPEfrom Creative Diagnostics |
|
CABT-48789MH | 100 TEST: 852.00 EUR | |
Mouse Anti Human Hla B7 Monoclonal Antibody,FITCfrom Creative Diagnostics |
|
CABT-48787MH | 0.1 mg: 852.00 EUR | |
Human HLA-B7 AssayLite™ Antibody (FITC Conjugate)from AssayPro |
|
78013-05141 | 2 x 50 ug: 370.00 EUR | |
HLA-A, HLA-B + HLA-C Antibodyfrom GenWay Biotech |
|
GWB-249D0F | 0.5 ml: Ask for price | |
HLA-DR, HLA-DP + HLA-DQ Antibodyfrom GenWay Biotech |
|
GWB-670561 | 1 ml: Ask for price | |
Mouse monoclonal Anti-HLA-B7 Clone BB7.1from Origene Technologies GmbH |
|
TA353220L | 500 µg: Ask for price | |
HLA-DP + HLA-DQ + HLA-DR Antibody (MHC II)from NSJ Bioreagents |
|
V3374-100UG | 100 ug: 424.15 EUR | |
Description: This mAb reacts with a common epitope of human major histocompatibility (MHC) class II antigens, HLA-DP, -DQ and -DR. Human MHC class II antigens are transmembrane glycoproteins composed of an alpha chain (36kDa) and a beta chain (27kDa). They are expressed primarily on antigen presenting cells such as B lymphocytes, monocytes, macrophages, and thymic epithelial cells and are also present on activated T lymphocytes. Human MHC class II genes are located in the HLA-D region that encodes at least six alpha and ten beta chain genes. Three loci, DR, DQ and DP, encode the major expressed products of the human class II region. The human MHC class II molecules bind intracellularly processed peptides and present them to T-helper cells. They, therefore, have a critical role in the initiation of the immune response. It has been shown that some auto-immune diseases are associated with certain class II alleles. |
|
HLA-DP + HLA-DQ + HLA-DR Antibody (MHC II)from NSJ Bioreagents |
|
V3374-20UG | 20 ug: 186.15 EUR | |
Description: This mAb reacts with a common epitope of human major histocompatibility (MHC) class II antigens, HLA-DP, -DQ and -DR. Human MHC class II antigens are transmembrane glycoproteins composed of an alpha chain (36kDa) and a beta chain (27kDa). They are expressed primarily on antigen presenting cells such as B lymphocytes, monocytes, macrophages, and thymic epithelial cells and are also present on activated T lymphocytes. Human MHC class II genes are located in the HLA-D region that encodes at least six alpha and ten beta chain genes. Three loci, DR, DQ and DP, encode the major expressed products of the human class II region. The human MHC class II molecules bind intracellularly processed peptides and present them to T-helper cells. They, therefore, have a critical role in the initiation of the immune response. It has been shown that some auto-immune diseases are associated with certain class II alleles. |
|
HLA-DP + HLA-DQ + HLA-DR Antibody (MHC II)from NSJ Bioreagents |
|
V3374SAF-100UG | 100 ug: 424.15 EUR | |
Description: This mAb reacts with a common epitope of human major histocompatibility (MHC) class II antigens, HLA-DP, -DQ and -DR. Human MHC class II antigens are transmembrane glycoproteins composed of an alpha chain (36kDa) and a beta chain (27kDa). They are expressed primarily on antigen presenting cells such as B lymphocytes, monocytes, macrophages, and thymic epithelial cells and are also present on activated T lymphocytes. Human MHC class II genes are located in the HLA-D region that encodes at least six alpha and ten beta chain genes. Three loci, DR, DQ and DP, encode the major expressed products of the human class II region. The human MHC class II molecules bind intracellularly processed peptides and present them to T-helper cells. They, therefore, have a critical role in the initiation of the immune response. It has been shown that some auto-immune diseases are associated with certain class II alleles. |
|
HLA-DR + HLA-DP Antibodyfrom GenWay Biotech |
|
GWB-17041A | 0.1 mg: Ask for price | |
HLA-DR + HLA-DP Antibodyfrom GenWay Biotech |
|
GWB-909520 | 0.1 mg: Ask for price | |
HLA-DR + HLA-DP Antibodyfrom GenWay Biotech |
|
GWB-A9925F | 0.1 mg: Ask for price | |
HLA-DRA Antibody / HLA-DRfrom NSJ Bioreagents |
|
RQ5585 | 100 ug: 356.15 EUR | |
Description: HLA class II histocompatibility antigen, DR alpha chainis a protein that in humans is encoded by the HLA-DRA gene. It is mapped to 6p21.32. HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. |
|
HLA-DQ1 + HLA-DQ3 Antibodyfrom GenWay Biotech |
|
GWB-7519A5 | 0.1 mg: Ask for price | |
HLA-Aw32 + HLA-A25 Antibodyfrom NSJ Bioreagents |
|
V2572-100UG | 100 ug: 424.15 EUR | |
Description: This mAb reacts with cells bearing HLA-A25 or HLA-Aw32 antigens. In addition, a reaction was observed with a cell of phenotype A2, Aw31; B17, Bw49. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. HLA system comprises closely linked genes controlling highly polymorphic proteins involved in the presentation of peptides to the T-cell receptor, inhibition of NK cell cytotoxicity, and rejection of tissue allotransplantation. Specific alleles at HLA loci are associated with diseases. This mAb is specifically applicable for typing peripheral T cells for the antigens HLA-A25 and HLA-Aw32. |
|
HLA-Aw32 + HLA-A25 Antibodyfrom NSJ Bioreagents |
|
V2572-20UG | 20 ug: 186.15 EUR | |
Description: This mAb reacts with cells bearing HLA-A25 or HLA-Aw32 antigens. In addition, a reaction was observed with a cell of phenotype A2, Aw31; B17, Bw49. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. HLA system comprises closely linked genes controlling highly polymorphic proteins involved in the presentation of peptides to the T-cell receptor, inhibition of NK cell cytotoxicity, and rejection of tissue allotransplantation. Specific alleles at HLA loci are associated with diseases. This mAb is specifically applicable for typing peripheral T cells for the antigens HLA-A25 and HLA-Aw32. |
|
HLA-Aw32 + HLA-A25 Antibodyfrom NSJ Bioreagents |
|
V2572IHC-7ML | 7 ml: 424.15 EUR | |
Description: This mAb reacts with cells bearing HLA-A25 or HLA-Aw32 antigens. In addition, a reaction was observed with a cell of phenotype A2, Aw31; B17, Bw49. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. HLA system comprises closely linked genes controlling highly polymorphic proteins involved in the presentation of peptides to the T-cell receptor, inhibition of NK cell cytotoxicity, and rejection of tissue allotransplantation. Specific alleles at HLA loci are associated with diseases. This mAb is specifically applicable for typing peripheral T cells for the antigens HLA-A25 and HLA-Aw32. |
|
HLA-Aw32 + HLA-A25 Antibodyfrom NSJ Bioreagents |
|
V2572SAF-100UG | 100 ug: 424.15 EUR | |
Description: This mAb reacts with cells bearing HLA-A25 or HLA-Aw32 antigens. In addition, a reaction was observed with a cell of phenotype A2, Aw31; B17, Bw49. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. HLA system comprises closely linked genes controlling highly polymorphic proteins involved in the presentation of peptides to the T-cell receptor, inhibition of NK cell cytotoxicity, and rejection of tissue allotransplantation. Specific alleles at HLA loci are associated with diseases. This mAb is specifically applicable for typing peripheral T cells for the antigens HLA-A25 and HLA-Aw32. |
|
HLA-Aw32 + HLA-A25 Antibodyfrom NSJ Bioreagents |
|
V2573-100UG | 100 ug: 424.15 EUR | |
Description: This mAb reacts with cells bearing HLA-A25 or HLA-Aw32 antigens. In addition, a reaction was observed with a cell of phenotype A2, Aw31; B17, Bw49. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. HLA system comprises closely linked genes controlling highly polymorphic proteins involved in the presentation of peptides to the T-cell receptor, inhibition of NK cell cytotoxicity, and rejection of tissue allotransplantation. Specific alleles at HLA loci are associated with diseases. This mAb is specifically applicable for typing peripheral T cells for the antigens HLA-A25 and HLA-Aw32. |
|
HLA-Aw32 + HLA-A25 Antibodyfrom NSJ Bioreagents |
|
V2573-20UG | 20 ug: 186.15 EUR | |
Description: This mAb reacts with cells bearing HLA-A25 or HLA-Aw32 antigens. In addition, a reaction was observed with a cell of phenotype A2, Aw31; B17, Bw49. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. HLA system comprises closely linked genes controlling highly polymorphic proteins involved in the presentation of peptides to the T-cell receptor, inhibition of NK cell cytotoxicity, and rejection of tissue allotransplantation. Specific alleles at HLA loci are associated with diseases. This mAb is specifically applicable for typing peripheral T cells for the antigens HLA-A25 and HLA-Aw32. |
|
HLA-Aw32 + HLA-A25 Antibodyfrom NSJ Bioreagents |
|
V2573IHC-7ML | 7 ml: 424.15 EUR | |
Description: This mAb reacts with cells bearing HLA-A25 or HLA-Aw32 antigens. In addition, a reaction was observed with a cell of phenotype A2, Aw31; B17, Bw49. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. HLA system comprises closely linked genes controlling highly polymorphic proteins involved in the presentation of peptides to the T-cell receptor, inhibition of NK cell cytotoxicity, and rejection of tissue allotransplantation. Specific alleles at HLA loci are associated with diseases. This mAb is specifically applicable for typing peripheral T cells for the antigens HLA-A25 and HLA-Aw32. |
|
HLA-Aw32 + HLA-A25 Antibodyfrom NSJ Bioreagents |
|
V2573SAF-100UG | 100 ug: 424.15 EUR | |
Description: This mAb reacts with cells bearing HLA-A25 or HLA-Aw32 antigens. In addition, a reaction was observed with a cell of phenotype A2, Aw31; B17, Bw49. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. HLA system comprises closely linked genes controlling highly polymorphic proteins involved in the presentation of peptides to the T-cell receptor, inhibition of NK cell cytotoxicity, and rejection of tissue allotransplantation. Specific alleles at HLA loci are associated with diseases. This mAb is specifically applicable for typing peripheral T cells for the antigens HLA-A25 and HLA-Aw32. |
|
HLA-Aw32 + HLA-A25 Antibodyfrom NSJ Bioreagents |
|
V2574-100UG | 100 ug: 424.15 EUR | |
Description: This mAb reacts with cells bearing HLA-A25 or HLA-Aw32 antigens. In addition, a reaction was observed with a cell of phenotype A2, Aw31; B17, Bw49. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. HLA system comprises closely linked genes controlling highly polymorphic proteins involved in the presentation of peptides to the T-cell receptor, inhibition of NK cell cytotoxicity, and rejection of tissue allotransplantation. Specific alleles at HLA loci are associated with diseases. This mAb is specifically applicable for typing peripheral T cells for the antigens HLA-A25 and HLA-Aw32. |
|
HLA-Aw32 + HLA-A25 Antibodyfrom NSJ Bioreagents |
|
V2574-20UG | 20 ug: 186.15 EUR | |
Description: This mAb reacts with cells bearing HLA-A25 or HLA-Aw32 antigens. In addition, a reaction was observed with a cell of phenotype A2, Aw31; B17, Bw49. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. HLA system comprises closely linked genes controlling highly polymorphic proteins involved in the presentation of peptides to the T-cell receptor, inhibition of NK cell cytotoxicity, and rejection of tissue allotransplantation. Specific alleles at HLA loci are associated with diseases. This mAb is specifically applicable for typing peripheral T cells for the antigens HLA-A25 and HLA-Aw32. |
|
HLA-Aw32 + HLA-A25 Antibodyfrom NSJ Bioreagents |
|
V2574IHC-7ML | 7 ml: 424.15 EUR | |
Description: This mAb reacts with cells bearing HLA-A25 or HLA-Aw32 antigens. In addition, a reaction was observed with a cell of phenotype A2, Aw31; B17, Bw49. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. HLA system comprises closely linked genes controlling highly polymorphic proteins involved in the presentation of peptides to the T-cell receptor, inhibition of NK cell cytotoxicity, and rejection of tissue allotransplantation. Specific alleles at HLA loci are associated with diseases. This mAb is specifically applicable for typing peripheral T cells for the antigens HLA-A25 and HLA-Aw32. |
|
HLA-Aw32 + HLA-A25 Antibodyfrom NSJ Bioreagents |
|
V2574SAF-100UG | 100 ug: 424.15 EUR | |
Description: This mAb reacts with cells bearing HLA-A25 or HLA-Aw32 antigens. In addition, a reaction was observed with a cell of phenotype A2, Aw31; B17, Bw49. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. HLA system comprises closely linked genes controlling highly polymorphic proteins involved in the presentation of peptides to the T-cell receptor, inhibition of NK cell cytotoxicity, and rejection of tissue allotransplantation. Specific alleles at HLA loci are associated with diseases. This mAb is specifically applicable for typing peripheral T cells for the antigens HLA-A25 and HLA-Aw32. |
|
HLA-DQA2 & HLA-DQA1 Antibodyfrom Abbexa |
|
abx432803-200ul | 200 ul: 460.80 EUR | |
HLA-DQB1 / HLA-DQB2 Antibodyfrom Abbexa |
|
20-abx323712 | [ 100 ug: Ask for price ] [ 50 ug: Ask for price ] | |
HLA-DQB1/HLA-DQB2 Antibodyfrom Cusabio |
|
1-CSB-PA005915 | [ 100ug: Ask for price ] [ 50ug: Ask for price ] | |
Description: A polyclonal antibody against HLA-DQB1/HLA-DQB2. Recognizes HLA-DQB1/HLA-DQB2 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
|
HLA-DQA2 & HLA-DQA1 Antibodyfrom Abbexa |
|
abx432803-100g | 100 µg: 387.50 EUR | |
HLA-DQB1 / HLA-DQB2 Antibodyfrom Abbexa |
|
abx323712-100g | 100 µg: 250.00 EUR | |
HLA-DQB1 / HLA-DQB2 Antibodyfrom Abbexa |
|
abx323712-50g | 50 µg: 187.50 EUR | |
HLA-DR + HLA-DP + HLA-DQ Antibody (ready to use)from GenWay Biotech |
|
GWB-8F7A18 | 6 ml: Ask for price | |
HLA class I (HLA-A) Antibodyfrom Abbexa |
|
abx233895-100ug | 100 ug: 661.20 EUR | |
HLA class I (HLA-A) Antibodyfrom Abbexa |
|
abx233896-100ug | 100 ug: 661.20 EUR | |
HLA class I (HLA-B) Antibodyfrom Abbexa |
|
abx233897-100ug | 100 ug: 661.20 EUR | |
HLA class I (HLA-C) Antibodyfrom Abbexa |
|
abx233898-100ug | 100 ug: 661.20 EUR | |
Human HLA-B protein (HLA-B)from Cusabio |
|
1-CSB-RP150894h | [ 100ug: Ask for price ] [ 10ug: Ask for price ] [ 1MG: Ask for price ] [ 200ug: Ask for price ] [ 500ug: Ask for price ] [ 50ug: Ask for price ] | |
Description: Recombinant Human HLA-B protein(HLA-B),partial expressed in E.coli |
|
Human HLA-C protein (HLA-C)from Cusabio |
|
1-CSB-RP150994h | [ 100ug: Ask for price ] [ 10ug: Ask for price ] [ 1MG: Ask for price ] [ 200ug: Ask for price ] [ 500ug: Ask for price ] [ 50ug: Ask for price ] | |
Description: Recombinant Human HLA-C protein(HLA-C),partial expressed in E.coli |
|
HLA class I (HLA-A) Antibodyfrom Abbexa |
|
abx233895-100g | 100 µg: 350.00 EUR | |
HLA class I (HLA-A) Antibodyfrom Abbexa |
|
abx233896-100g | 100 µg: 350.00 EUR | |
HLA class I (HLA-B) Antibodyfrom Abbexa |
|
abx233897-100g | 100 µg: 350.00 EUR | |
HLA class I (HLA-C) Antibodyfrom Abbexa |
|
abx233898-100g | 100 µg: 350.00 EUR | |
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC811067-100 | 100uL: 238.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF680R conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC811067-500 | 500uL: 652.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF680R conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC801067-100 | 100uL: 238.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF680 conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC801067-500 | 500uL: 652.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF680 conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC431067-100 | 100uL: 238.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF543 conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC431067-500 | 500uL: 652.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF543 conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC051067-100 | 100uL: 238.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF405M conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC051067-500 | 500uL: 652.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF405M conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC551067-100 | 100uL: 238.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF555 conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC551067-500 | 500uL: 652.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF555 conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC701067-100 | 100uL: 238.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF770 conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC701067-500 | 500uL: 652.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF770 conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC611067-100 | 100uL: 238.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF660R conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNC611067-500 | 500uL: 652.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), CF660R conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNCP1067-250 | 250uL: 459.60 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), PerCP conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNCR1067-250 | 250uL: 459.60 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), RPE conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNCA1067-250 | 250uL: 459.60 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), APC conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNCH1067-100 | 100uL: 238.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNCH1067-500 | 500uL: 652.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNCAP1067-100 | 100uL: 238.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|
HLA-DRB(HLA-DRB/1067) Antibodyfrom Biotium |
|
BNCAP1067-500 | 500uL: 652.80 EUR | |
Description: Primary antibody against HLA-DRB(HLA-DRB/1067), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|
HLA-DR + HLA-DP Antibody (FITC)from GenWay Biotech |
|
GWB-5831D9 | 100 TESTS: Ask for price | |
Human HLA-DMA protein (HLA-DMA)from Cusabio |
|
1-CSB-EP338892HU | [ 100ug: Ask for price ] [ 10ug: Ask for price ] [ 1MG: Ask for price ] [ 200ug: Ask for price ] [ 500ug: Ask for price ] [ 50ug: Ask for price ] | |
Description: Recombinant Human HLA-DMA protein(HLA-DMA),partial expressed in E.coli |
|
HLA-DRB(HLA-DRB/1067), 0.2mg/mLfrom Biotium |
|
BNUB1067-100 | 100uL: 225.00 EUR | |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |